These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31349225)

  • 21. The Safety and Efficacy of Concurrent Immune Checkpoint Blockade and Stereotactic Radiosurgery Therapy with Practitioner and Researcher Recommendations.
    Mehkri Y; Windermere SA; Still MEH; Yan SC; Goutnik M; Melnick K; Doonan B; Ghiaseddin AP; Rahman M
    World Neurosurg; 2024 Jan; 181():e133-e153. PubMed ID: 37739175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of conformity index and gradient index in patients undergoing stereotactic radiosurgery for a single metastatic tumor.
    Aiyama H; Yamamoto M; Kawabe T; Watanabe S; Koiso T; Sato Y; Higuchi Y; Ishikawa E; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):103-110. PubMed ID: 30544326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
    Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
    [No Abstract]   [Full Text] [Related]  

  • 24. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
    Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
    J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
    Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP
    J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients.
    Lehrer EJ; Khosla AA; Ozair A; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Mathieu D; Trudel C; Deibert CP; Malouff TD; Ruiz-Garcia H; Peterson JL; Patel S; Bonney P; Hwang L; Yu C; Zada G; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Fakhoury KR; Rusthoven CG; Dickstein DR; Sheehan JP; Trifiletti DM; Ahluwalia MS
    J Neurooncol; 2023 Oct; 165(1):63-77. PubMed ID: 37889444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
    Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery for melanoma brain metastases: Concurrent immune checkpoint inhibitor therapy associated with superior clinicoradiological response outcomes.
    Shanker MD; Garimall S; Gatt N; Foley H; Crowley S; Le Cornu E; Muscat K; Soon W; Atkinson V; Xu W; Watkins T; Huo M; Foote MC; Pinkham MB
    J Med Imaging Radiat Oncol; 2022 Jun; 66(4):536-545. PubMed ID: 35343063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
    Chiang CL; Yang HC; Luo YH; Chen CJ; Wu HM; Chen YM; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Chou TY; Pan DH; Lee CC
    J Neurosurg; 2023 Aug; 139(2):385-392. PubMed ID: 36681978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.
    Kim PH; Suh CH; Kim HS; Kim KW; Kim DY; Aizer AA; Rahman R; Guenette JP; Huang RY
    Eur Radiol; 2021 Jun; 31(6):4114-4129. PubMed ID: 33241519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer.
    Wang SJ; Khullar K; Kim S; Yegya-Raman N; Malhotra J; Groisberg R; Crayton SH; Silk AW; Nosher JL; Gentile MA; Mehnert JM; Jabbour SK
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE).
    Rusthoven CG; Staley AW; Gao D; Yomo S; Bernhardt D; Wandrey N; El Shafie R; Kraemer A; Padilla O; Chiang V; Faramand AM; Palmer JD; Zacharia BE; Wegner RE; Hattangadi-Gluth JA; Levy A; Bernstein K; Mathieu D; Cagney DN; Chan MD; Grills IS; Braunstein S; Lee CC; Sheehan JP; Kluwe C; Patel S; Halasz LM; Andratschke N; Deibert CP; Verma V; Trifiletti DM; Cifarelli CP; Debus J; Combs SE; Sato Y; Higuchi Y; Aoyagi K; Brown PD; Alami V; Niranjan A; Lunsford LD; Kondziolka D; Camidge DR; Kavanagh BD; Robin TP; Serizawa T; Yamamoto M
    J Natl Cancer Inst; 2023 Aug; 115(8):926-936. PubMed ID: 37142267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis.
    Lee E; Chen X; LeCompte MC; Kleinberg LR; Hales RK; Voong KR; Forde PM; Brahmer JR; Markowski MC; Lipson EJ; Lee SH; Bydon A; Lo SL; Lubelski D; Redmond KJ
    J Neurosurg Spine; 2023 Aug; 39(2):278-286. PubMed ID: 37148233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it advisable to perform radiosurgery for EGFR-TKI-controlled brain metastases? A retrospective study of the role of radiosurgery in lung cancer treatment.
    Hung JS; Su YH; Chen CJ; Chiang CL; Shen CI; Yang HC; Shiau CY; Luo YH; Wu HM; Hu YS; Lin CJ; Liu KD; Chung WY; Guo WY; Lee CC
    J Neurooncol; 2023 Sep; 164(2):413-422. PubMed ID: 37656378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Stereotactic Body Radiation Therapy on Diverse Organ Lesions in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
    Zhu KK; Wei JL; Xu YH; Li J; Rao XR; Xu YZ; Xing BY; Zhang SJ; Chen LC; Dong XR; Zhang S; Li ZY; Liu CW; Meng R; Wu G
    Curr Med Sci; 2023 Apr; 43(2):344-359. PubMed ID: 37002471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses.
    Kuan AS; Chiang CL; Wu HM; Yang HC; Chen CJ; Lin CJ; Guo WY; Pan DH; Chung WY; Lee CC
    J Neurooncol; 2023 Sep; 164(3):729-739. PubMed ID: 37721662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.